Monday, March 3rd 2025, 5:50 am
The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over. After nearly three years of high demand and supply chain issues, semaglutide injections are now readily available.
A: Local pharmacies that have been producing compounded versions of these drugs will need to stop. Under new FDA rules, state-licensed pharmacies must stop by April 22, and larger facilities must comply by May 22.
A: Experts warn that compounded versions of weight-loss drugs pose safety risks, such as dosing errors. Kristie Edelen from the Oklahoma Poison Center explains that these versions are often sold online or through clinics without a prescription, leading to potential overdosing and severe side effects like nausea, cramping, and dehydration.
A: Oklahoma Attorney General Gentner Drummond, along with 37 other state attorneys general, is urging the FDA to take stronger action against counterfeit weight-loss drugs. These illegal drugs, often sold online, may contain harmful contaminants or unknown substances, posing serious risks to consumers.
A: Patients are encouraged to double-check their doses and consult a doctor or pharmacist if they have any concerns. They can also contact the Oklahoma Poison Center for guidance.
A: Edelen reports that 78% of calls they receive are related to unintentional therapeutic errors, such as accidentally injecting the wrong amount of the drug or using the wrong syringe.
A: The Oklahoma Poison Center offers 24/7 support for anyone with concerns about medication safety. Patients can reach out for assistance if they suspect issues with their medications.
April 16th, 2025
April 16th, 2025
April 16th, 2025
April 16th, 2025
April 16th, 2025
April 16th, 2025